Decelerating decay of latently infected cells during prolonged therapy for human immunodeficiency virus type 1 infection

Journal of Virology

Volumn 76, Issue 17, 2002, Pages 8963-8965

  Müller, Viktor ^a   Vigueras Gómez, Javier Flavio ^a   Bonhoeffer, Sebastian ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; PRIORITY JOURNAL; VIREMIA; VIRUS PARTICLE; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL; TIME FACTORS; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 0036334097     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.17.8963-8965.2002     Document Type: Article

References (27)

1. HIV-1 dynamics revisited: Biphasic decay by cytotoxic T lymphocyte killing?
2. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection
3. HIV-1 infection and low steady state viral loads
4. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
5. Re-emergence of HIV after stopping therapy
6. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
7. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy
8. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
9. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression
10. Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
11. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
12. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
13. Ongoing HIV dissemination during HAART
14. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent anti-retroviral therapy
15. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
16. Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood
17. Decay characteristics of HIV-1-infected compartments during combination therapy
18. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
19. + T lymphocytes in infected children
20. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
21. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
22. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
23. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy
24. Viral dynamics in human immunodeficiency virus type 1 infection
25. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
26. Genetic characterization of rebounding HIV-1 after cessation of highly active anti-retroviral therapy
27. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy